Literature DB >> 10845855

Interactions of oxidants with vascular signaling systems.

M S Wolin1.   

Abstract

Individual reactive oxygen species (ROS) and oxidation products of NO interact with vascular signaling mechanisms in ways that appear to have fundamental roles in the control of vascular physiological and pathophysiological function. The activities of ROS-producing systems (including various NADPH and NADH oxidases, xanthine oxidase, and NO synthase) in endothelium and/or vascular smooth muscle are controlled by receptor activation, oxygen tension, metabolic processes, and physiological forces associated with blood pressure and flow. This review focuses on how the chemical properties and metabolic sensing interactions of individual ROS (including superoxide anion, hydrogen peroxide, and peroxynitrite) interact with cellular regulatory systems to produce vascular responses. These species appear to often function through producing selective alterations in individual heme or thiol redox-regulated systems (including guanylate cyclase, cyclooxygenase, mitochondrial electron transport, and tyrosine phosphatases) to initiate physiological responses through signaling pathways that control phospholipases, protein kinases, ion channels, contractile proteins, and gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845855     DOI: 10.1161/01.atv.20.6.1430

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  93 in total

Review 1.  New concepts in vascular nitric oxide signaling.

Authors:  R A Oeckler; M S Wolin
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

2.  Differential regulation of the slow and rapid components of guinea-pig cardiac delayed rectifier K+ channels by hypoxia.

Authors:  Livia C Hool
Journal:  J Physiol       Date:  2003-11-21       Impact factor: 5.182

Review 3.  Lesions and lipids and radicals--O my!

Authors:  James M Wilson; Brian Walton
Journal:  Tex Heart Inst J       Date:  2004

Review 4.  Should antioxidant status be considered in interventional trials with antioxidants?

Authors:  F Violi; L Loffredo; L Musella; A Marcoccia
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

5.  Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.

Authors:  H Zheng; X Huang; Q Zhang; S D Katz
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

6.  Inhibition of inducible nitric oxide synthase prevents graft injury after transplantation of livers from rats after cardiac death.

Authors:  Yanjun Shi; Hasibur Rehman; Gary L Wright; Zhi Zhong
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

7.  Oxygen-derived free radicals mediate endothelium-dependent contractions in femoral arteries of rats with streptozotocin-induced diabetes.

Authors:  Y Shi; K-F So; R Y K Man; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

8.  Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.

Authors:  Julian M Stewart; Indu Taneja; June Glover; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-11-09       Impact factor: 4.733

Review 9.  Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia.

Authors:  Costantino Iadecola
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

Review 10.  Mechanisms of homocysteine-induced glomerular injury and sclerosis.

Authors:  Fan Yi; Pin-Lan Li
Journal:  Am J Nephrol       Date:  2007-11-07       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.